CoChat

Biofilm antimicrobial susceptibility through an experimental evolutionary lens

Coenye, Tom, Bové, Mona, Bjarnsholt, Thomas · 2022 · npj Biofilms and Microbiomes
Cited by 62

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Experimental evolution experiments in which bacterial populations are repeatedly exposed to an antimicrobial treatment, and examination of the genotype and phenotype of the resulting evolved bacteria, can help shed light on mechanisms behind reduced susceptibility. In this review we present an overview of why it is important to include biofilms in experimental evolution, which approaches are available to study experimental evolution in biofilms and what experimental evolution has taught us about tolerance and resistance in biofilms. Finally, we present an emerging consensus view on biofilm antimicrobial susceptibility supported by data obtained during experimental evolution studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41522-022-00346-4

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 138

  1. Haas, J. W. The Reverend Dr William Henry Dallinger, F.R.S. (1839–1909). Notes Rec. R. Soc. Lond. 54, 53–65 (2000). · DOI
  2. Atwood, K. C., Schneider, L. K. & Ryan, F. J. Periodic selection in Escherichia coli. Proc. Natl. Acad. Sci. USA 37, 146–155 (1951). · DOI · Paper page
  3. Lenski, R. E. Convergence and divergence in a long-term experiment with bacteria. Am. Nat. 190, S57–S68 (2017). · DOI · Paper page
  4. Lenski, R. E. Experimental evolution and the dynamics of adaptation and genome evolution in microbial populations. ISME J. 11, 2181–2194 (2017). · DOI · Paper page
  5. Korona, R., Nakatsu, C. H., Forney, L. J. & Lenski, R. E. Evidence for multiple adaptive peaks from populations of bacteria evolving in a structured habitat. Proc. Natl. Acad. Sci. USA 91, 9037–9041 (1994). · DOI · Paper page
  6. Rainey, P. B. & Travisano, M. Adaptive radiation in a heterogeneous environment. Nature 394, 69–72 (1998). · DOI · Paper page
  7. Sauer, K. et al. The biofilm life cycle: expanding the conceptual model of biofilm formation. Nat. Rev. Microbiol. 20, 608–620 (2022). · DOI · Paper page
  8. Stewart, P. S. & Franklin, M. J. Physiological heterogeneity in biofilms. Nat. Rev. Microbiol. 6, 199–210 (2008). · DOI · Paper page
  9. Sonderholm, M. et al. Pseudomonas aeruginosa aggregate formation in an alginate bead model system exhibits in vivo-like characteristics. Appl. Environ. Microbiol. 83, e00113–17 (2017). · DOI · Paper page
  10. Bjarnsholt, T. et al. The importance of understanding the infectious microenvironment. Lancet Infect. Dis. 22, e88–e92 (2022). · DOI · Paper page
  11. Ciofu, O., Moser, C., Jensen, P. O. & Hoiby, N. Tolerance and resistance of microbial biofilms. Nat. Rev. Microbiol. 20, 621–635 (2022). · DOI · Paper page
  12. Livingston, J., Spero, M. A., Lonergan, Z. R. & Newman, D. K. Visualization of mRNA expression in Pseudomonas aeruginosa aggregates reveals spatial patterns of fermentative and denitrifying metabolism. Appl. Environ. Microbiol. 88, e0043922 (2022). · DOI
  13. Van den Bergh, B., Swings, T., Fauvart, M. & Michiels, J. Experimental design, population Dynamics, and diversity in microbial experimental evolution. Microbiol. Mol. Biol. Rev. 82, e00008–18 (2018). · DOI · Paper page
  14. Steenackers, H. P., Parijs, I., Dubey, A., Foster, K. R. & Vanderleyden, J. Experimental evolution in biofilm populations. FEMS Microbiol. Rev. 40, 373–397 (2016). · DOI · Paper page
  15. Habets, M. G., Rozen, D. E., Hoekstra, R. F. & de Visser, J. A. The effect of population structure on the adaptive radiation of microbial populations evolving in spatially structured environments. Ecol. Lett. 9, 1041–1048 (2006). · DOI
  16. Poltak, S. R. & Cooper, V. S. Ecological succession in long-term experimentally evolved biofilms produces synergistic communities. ISME J. 5, 369–378 (2011). · DOI · Paper page
  17. Armbruster, C. R. et al. Adaptation and genomic erosion in fragmented Pseudomonas aeruginosa populations in the sinuses of people with cystic fibrosis. Cell Rep. 37, 109829 (2021). · DOI
  18. Rozen, D. E., Habets, M. G., Handel, A. & de Visser, J. A. Heterogeneous adaptive trajectories of small populations on complex fitness landscapes. PLoS One 3, e1715 (2008). · DOI · Paper page
  19. Chakraborty, P. P., Nemzer, L. R. & Kassen, R. Experimental evidence that metapopulation structure can accelerate adaptive evolution. bioRxiv https://doi.org/10.1101/2021.07.13.452242 (2021). · doi:10.1101/2021.07.13.452242
  20. Martens, E. A. & Hallatschek, O. Interfering waves of adaptation promote spatial mixing. Genetics 189, 1045–1060 (2011). · DOI
  21. Traverse, C. C., Mayo-Smith, L. M., Poltak, S. R. & Cooper, V. S. Tangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infections. Proc. Natl. Acad. Sci. USA 110, E250–E259 (2013). · DOI · Paper page
  22. Harris, K. B., Flynn, K. M. & Cooper, V. S. Polygenic adaptation and clonal interference enable sustained diversity in experimental pseudomonas aeruginosa populations. Mol. Biol. evolution 38, 5359–5375 (2021). · DOI
  23. Schick, A. & Kassen, R. Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions. Proc. Natl. Acad. Sci. USA 115, 10714–10719 (2018). · DOI
  24. Schick, A., Shewaramani, S. & Kassen, R. Genomics of diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions. Genome Biol. Evol. 14, evac074 (2022). · DOI
  25. Stewart, P. S. Diffusion in biofilms. J. Bacteriol. 185, 1485–1491 (2003). · DOI · Paper page
  26. Davies, S. K. et al. Visualizing antimicrobials in bacterial biofilms: three-dimensional biochemical imaging using TOF-SIMS. mSphere 2, e00211–17 (2017). · DOI
  27. Stewart, P. S. et al. Conceptual model of biofilm antibiotic tolerance that integrates phenomena of diffusion, metabolism, gene expression, and physiology. J. Bacteriol. 201, e00307–19 (2019). · DOI · Paper page
  28. Baquero, F., Negri, M. C., Morosini, M. I. & Blazquez, J. Antibiotic-selective environments. Clin. Infect. Dis. 27, S5–S11 (1998). · DOI · Paper page
  29. Baquero, F. et al. Evolutionary pathways and trajectories in antibiotic resistance. Clin. Microbiol. Rev. 34, e0005019 (2021). · DOI · Paper page
  30. Jansen, G., Barbosa, C. & Schulenburg, H. Experimental evolution as an efficient tool to dissect adaptive paths to antibiotic resistance. Drug Resist. Update. 16, 96–107 (2013). · DOI
  31. Adler, M., Anjum, M., Andersson, D. I. & Sandegren, L. Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli. J. Antimicrobial Chemother. 71, 1188–1198 (2016). · DOI · Paper page
  32. Langevin, A. M., El Meouche, I. & Dunlop, M. J. Mapping the role of AcrAB-TolC efflux pumps in the evolution of antibiotic resistance reveals near-MIC treatments facilitate resistance acquisition. mSphere 5, e01056–20 (2020). · DOI
  33. Zhang, G., Wang, C., Sui, Z. & Feng, J. Insights into the evolutionary trajectories of fluoroquinolone resistance in Streptococcus pneumoniae. J. Antimicrobial Chemother. 70, 2499–2506 (2015). · DOI
  34. Cabot, G. et al. Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates. Antimicrob. Agents Chemother. 60, 1767–1778 (2016). · DOI
  35. Crabbe, A., Jensen, P. O., Bjarnsholt, T. & Coenye, T. Antimicrobial tolerance and metabolic adaptations in microbial biofilms. Trends Microbiol. 27, 850–863 (2019). · DOI · Paper page
  36. Stokes, J. M., Lopatkin, A. J., Lobritz, M. A. & Collins, J. J. Bacterial metabolism and antibiotic efficacy. Cell Metab. 30, 251–259 (2019). · DOI · Paper page
  37. Zampieri, M. et al. Metabolic constraints on the evolution of antibiotic resistance. Mol. Syst. Biol. 13, 917 (2017). · DOI · Paper page
  38. Lopatkin, A. J. et al. Clinically relevant mutations in core metabolic genes confer antibiotic resistance. Science 371, eaba0862 (2021). · DOI · Paper page
  39. Van Acker, H. & Coenye, T. The role of reactive oxygen species in antibiotic-mediated killing of bacteria. Trends Microbiol. 25, 456–466 (2017). · DOI · Paper page
  40. Meylan, S., Andrews, I. W. & Collins, J. J. Targeting antibiotic tolerance, pathogen by pathogen. Cell 172, 1228–1238 (2018). · DOI · Paper page
  41. Kester, J. C. & Fortune, S. M. Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria. Crit. Rev. Biochem. Mol. Biol. 49, 91–101 (2014). · DOI · Paper page
  42. Windels, E. M., Van den Bergh, B. & Michiels, J. Bacteria under antibiotic attack: different strategies for evolutionary adaptation. PLoS Pathog. 16, e1008431 (2020). · DOI
  43. Verstraete, L., Van den Bergh, B., Verstraeten, N. & Michiels, J. Ecology and evolution of antibiotic persistence. Trends Microbiol. 30, 466–479 (2022). · DOI
  44. Fridman, O., Goldberg, A., Ronin, I., Shoresh, N. & Balaban, N. Q. Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. Nature 513, 418–421 (2014). · DOI · Paper page
  45. Dengler Haunreiter, V. et al. In-host evolution of Staphylococcus epidermidis in a pacemaker-associated endocarditis resulting in increased antibiotic tolerance. Nat. Commun. 10, 1149 (2019). · DOI
  46. Jennings, L. K. et al. Pseudomonas aeruginosa aggregates in cystic fibrosis sputum produce exopolysaccharides that likely impede current therapies. Cell Rep. 34, 108782 (2021). · DOI · Paper page
  47. Chakraborty, P., Bajeli, S., Kaushal, D., Radotra, B. D. & Kumar, A. Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis. Nat. Commun. 12, 1606 (2021). · DOI · Paper page
  48. Sonderholm, M. et al. The consequences of being in an infectious biofilm: microenvironmental conditions governing antibiotic tolerance. Int. J. Mol. Sci. 18, 2688 (2017). · DOI
  49. Rossi, E. et al. Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat. Rev. Microbiol. 19, 331–342 (2021). · DOI · Paper page
  50. Michiels, J. E., Van den Bergh, B., Verstraeten, N., Fauvart, M. & Michiels, J. In vitro emergence of high persistence upon periodic aminoglycoside challenge in the ESKAPE pathogens. Antimicrob. Agents Chemother. 60, 4630–4637 (2016). · DOI
  51. Van den Bergh, B. et al. Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence. Nat. Microbiol. 1, 16020 (2016). · DOI · Paper page
  52. Levin-Reisman, I. et al. Antibiotic tolerance facilitates the evolution of resistance. Science 355, 826–830 (2017). · DOI · Paper page
  53. Santi, I., Manfredi, P., Maffei, E., Egli, A. & Jenal, U. Evolution of antibiotic tolerance shapes resistance development in chronic Pseudomonas aeruginosa infections. mBio 12, e03482–20 (2021). · DOI · Paper page
  54. Sebastian, J. et al. De Novo emergence of genetically resistant mutants of Mycobacterium tuberculosis from the persistence phase cells formed against antituberculosis drugs in vitro. Antimicrob. Agents Chemother. 61, e01343–16 (2017). · DOI · Paper page
  55. Vogwill, T., Comfort, A. C., Furio, V. & MacLean, R. C. Persistence and resistance as complementary bacterial adaptations to antibiotics. J. Evolut. Biol. 29, 1223–1233 (2016). · DOI
  56. Windels, E. M. et al. Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates. ISME J. 13, 1239–1251 (2019). · DOI · Paper page
  57. Coenye, T. & Nelis, H. J. In vitro and in vivo model systems to study microbial biofilm formation. J. Microbiol. Methods 83, 89–105 (2010). · DOI · Paper page
  58. Azeredo, J. et al. Critical review on biofilm methods. Crit. Rev. Microbiol. 43, 313–351 (2017). · DOI · Paper page
  59. Mai-Prochnow, H. K. N. V. B. X. A. Clinically relevant in vitro biofilm models: a need to mimic and recapitulate the host environment. Biofilm 4, 100069 (2022). · DOI
  60. Lebeaux, D., Chauhan, A., Rendueles, O. & Beloin, C. From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens. 2, 288–356 (2013). · DOI · Paper page
  61. Cooper, V. S., Staples, R. K., Traverse, C. C. & Ellis, C. N. Parallel evolution of small colony variants in Burkholderia cenocepacia biofilms. Genomics 104, 447–452 (2014). · DOI
  62. O’Rourke, D., FitzGerald, C. E., Traverse, C. C. & Cooper, V. S. There and back again: consequences of biofilm specialization under selection for dispersal. Front. Genet. 6, 18 (2015).
  63. Martin, M., Holscher, T., Dragos, A., Cooper, V. S. & Kovacs, A. T. Laboratory evolution of microbial interactions in bacterial biofilms. J. Bacteriol. 198, 2564–2571 (2016). · DOI
  64. Santos-Lopez, A., Marshall, C. W., Scribner, M. R., Snyder, D. J. & Cooper, V. S. Evolutionary pathways to antibiotic resistance are dependent upon environmental structure and bacterial lifestyle. eLife 8, e47612 (2019). · DOI · Paper page
  65. Sass, A. et al. Various evolutionary trajectories lead to loss of the tobramycin-potentiating activity of the Quorum-sensing inhibitor baicalin hydrate in Burkholderia cenocepacia biofilms. Antimicrob. Agents Chemother. 63, e02092–18 (2019). · DOI
  66. Oakley, J. L. et al. Phenotypic and genotypic adaptations in Pseudomonas aeruginosa biofilms following long-term exposure to an alginate oligomer therapy. mSphere 6, e01216–20 (2021). · DOI
  67. Trampari, E. et al. Exposure of Salmonella biofilms to antibiotic concentrations rapidly selects resistance with collateral tradeoffs. NPJ biofilms microbiomes 7, 3 (2021). · DOI · Paper page
  68. Scribner, M. R., Santos-Lopez, A., Marshall, C. W., Deitrick, C. & Cooper, V. S. Parallel evolution of tobramycin resistance across species and environments. mBio 11, e00932–20 (2020). · DOI · Paper page
  69. Ahmed, M. N., Porse, A., Sommer, M. O. A., Hoiby, N. & Ciofu, O. Evolution of antibiotic resistance in biofilm and planktonic Pseudomonas aeruginosa populations exposed to subinhibitory levels of ciprofloxacin. Antimicrob. Agents Chemother. 62, e00320–18 (2018). · DOI · Paper page
  70. Ahmed, M. N. et al. Lack of the major multifunctional catalase KatA in Pseudomonas aeruginosa accelerates evolution of antibiotic resistance in ciprofloxacin-treated biofilms. Antimicrob. Agents Chemother. 63, e00766–19 (2019). · DOI
  71. Maiden, M. M. & Waters, C. M. Triclosan depletes the membrane potential in Pseudomonas aeruginosa biofilms inhibiting aminoglycoside induced adaptive resistance. PLoS Pathog. 16, e1008529 (2020). · DOI
  72. Zaborskyte, G., Wistrand-Yuen, E., Hjort, K., Andersson, D. I. & Sandegren, L. Modular 3D-printed Peg biofilm device for flexible setup of surface-related biofilm studies. Front. Cell. Infect. Microbiol. 11, 802303 (2021). · DOI
  73. Hjort, K., Fermer, E., Tang, P. C. & Andersson, D. I. Antibiotic minimal selective concentrations and fitness costs during biofilm and planktonic growth. mBio 13, e0144722 (2022). · DOI
  74. France, M. T., Cornea, A., Kehlet-Delgado, H. & Forney, L. J. Spatial structure facilitates the accumulation and persistence of antibiotic-resistant mutants in biofilms. Evolut. Appl. 12, 498–507 (2019). · DOI · Paper page
  75. Miller, C. et al. Adaptation of Enterococcus faecalis to daptomycin reveals an ordered progression to resistance. Antimicrob. Agents Chemother. 57, 5373–5383 (2013). · DOI · Paper page
  76. Hammerstrom, T. G., Beabout, K., Clements, T. P., Saxer, G. & Shamoo, Y. Acinetobacter baumannii repeatedly evolves a hypermutator phenotype in response to tigecycline that effectively surveys evolutionary trajectories to resistance. PLoS One 10, e0140489 (2015). · DOI
  77. Mehta, H. H., Prater, A. G. & Shamoo, Y. Using experimental evolution to identify druggable targets that could inhibit the evolution of antimicrobial resistance. J. Antibiotics 71, 279–286 (2018). · DOI
  78. Zhang, Q. et al. Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments. Science 333, 1764–1767 (2011). · DOI · Paper page
  79. Zoheir, A. E., Spath, G. P., Niemeyer, C. M. & Rabe, K. S. Microfluidic evolution-on-a-chip reveals new mutations that cause antibiotic resistance. Small 17, e2007166 (2021). · DOI
  80. Tang, P. C. et al. A microfluidic chip for studies of the dynamics of antibiotic resistance selection in bacterial biofilms. Front. Cell. Infect. Microbiol. 12, 896149 (2022). · DOI
  81. Palmer, K. L., Aye, L. M. & Whiteley, M. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol. 189, 8079–8087 (2007). · DOI · Paper page
  82. Wong, A., Rodrigue, N. & Kassen, R. Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa. PLoS Genet. 8, e1002928 (2012). · DOI · Paper page
  83. Bove, M., Bao, X., Sass, A., Crabbe, A. & Coenye, T. The Quorum-sensing inhibitor furanone C-30 rapidly loses its tobramycin-potentiating activity against Pseudomonas aeruginosa biofilms during experimental evolution. Antimicrob. Agents Chemother. 65, e0041321 (2021). · DOI
  84. Drlica, K. & Zhao, X. Mutant selection window hypothesis updated. Clin. Infect. Dis. 44, 681–688 (2007). · DOI · Paper page
  85. Trubenova, B., Roizman, D., Moter, A., Rolff, J. & Regoes, R. R. Population genetics, biofilm recalcitrance, and antibiotic resistance evolution. Trends Microbiol. 30, 841–852 (2022). · DOI
  86. Sanz-Garcia, F., Sanchez, M. B., Hernando-Amado, S. & Martinez, J. L. Evolutionary landscapes of Pseudomonas aeruginosa towards ribosome-targeting antibiotic resistance depend on selection strength. Int. J. antimicrobial agents 55, 105965 (2020). · DOI
  87. Barrick, J. E. & Lenski, R. E. Genome dynamics during experimental evolution. Nat. Rev. Genet. 14, 827–839 (2013). · DOI · Paper page
  88. Bos, A. C., Passe, K. M., Mouton, J. W., Janssens, H. M. & Tiddens, H. A. The fate of inhaled antibiotics after deposition in cystic fibrosis: How to get drug to the bug? J. Cyst. Fibros. 16, 13–23 (2017). · doi:10.1016/j.jcf.2016.10.001
  89. van Os, W. & Zeitlinger, M. Predicting antimicrobial activity at the target site: pharmacokinetic/pharmacodynamic indices versus time-kill approaches. Antibiotics 10, 1485 (2021). · DOI
  90. Cao, B. et al. Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model. J. Antimicrobial Chemother. 70, 2057–2063 (2015). · DOI · Paper page
  91. Christophersen, L. et al. In vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartments. J. Cyst. Fibros. 19, 996–1003 (2020). · DOI · Paper page
  92. Messiaen, A. S., Forier, K., Nelis, H., Braeckmans, K. & Coenye, T. Transport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilms. PLoS One 8, e79220 (2013). · DOI
  93. Dwyer, D. J., Kohanski, M. A. & Collins, J. J. Role of reactive oxygen species in antibiotic action and resistance. Curr. Opin. Microbiol. 12, 482–489 (2009). · DOI · Paper page
  94. Zheng, E. J., Stokes, J. M. & Collins, J. J. Eradicating bacterial persisters with combinations of strongly and weakly metabolism-dependent antibiotics. Cell Chem. Biol. 27, 1544–1552.e1543 (2020). · DOI
  95. Zheng, E. J. et al. Modulating the evolutionary trajectory of tolerance using antibiotics with different metabolic dependencies. Nat. Commun. 13, 2525 (2022). · DOI
  96. Davies, E. V., James, C. E., Brockhurst, M. A. & Winstanley, C. Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model. BMC Microbiol. 17, 3 (2017). · DOI
  97. Usui, M., Yoshii, Y., Thiriet-Rupert, S., Ghigo, J.-M. & Beloin, C. Intermittent antibiotic treatment of bacterial biofilms favors the rapid evolution of resistance. bioRxiv https://doi.org/10.1101/2022.05.03.490405 (2022). · DOI
  98. Hansen, S. K., Rainey, P. B., Haagensen, J. A. & Molin, S. Evolution of species interactions in a biofilm community. Nature 445, 533–536 (2007). · DOI · Paper page
  99. Tognon, M. et al. Co-evolution with Staphylococcus aureus leads to lipopolysaccharide alterations in Pseudomonas aeruginosa. ISME J. 11, 2233–2243 (2017). · DOI
  100. Vandeplassche, E. et al. In vitro evolution of Pseudomonas aeruginosa AA2 biofilms in the presence of cystic fibrosis lung microbiome members. Sci. Rep. 9, 12859 (2019). · DOI
  101. Cairns, J., Jokela, R., Becks, L., Mustonen, V. & Hiltunen, T. Repeatable ecological dynamics govern the response of experimental communities to antibiotic pulse perturbation. Nat. Ecol. Evol. 4, 1385–1394 (2020). · DOI
  102. Cooper, V. S. et al. Experimental evolution in vivo to identify selective pressures during pneumococcal colonization. mSystems 5, e00352–20 (2020). · DOI
  103. Lebov, J. F., Schlomann, B. H., Robinson, C. D. & Bohannan, B. J. M. Phenotypic parallelism during experimental adaptation of a free-living bacterium to the zebrafish gut. mBio 11, e01519–20 (2020). · DOI
  104. Bove, M. & Coenye, T. The anti-virulence activity of the non-mevalonate pathway inhibitor FR900098 towards Burkholderia cenocepacia is maintained during experimental evolution. Microbiology 168, 001170 (2022). · doi:10.1099/mic.0.001170
  105. Thoming, J. G. et al. Parallel evolutionary paths to produce more than one Pseudomonas aeruginosa biofilm phenotype. NPJ Biofilms Microbiomes 6, 2 (2020). · DOI
  106. Thoming, J. G. & Haussler, S. Pseudomonas aeruginosa is more tolerant under biofilm than under planktonic growth conditions: a multi-isolate survey. Front. Cell. Infect. Microbiol. 12, 851784 (2022). · DOI
  107. Tyerman, J. G., Ponciano, J. M., Joyce, P., Forney, L. J. & Harmon, L. J. The evolution of antibiotic susceptibility and resistance during the formation of Escherichia coli biofilms in the absence of antibiotics. BMC Evolut. Biol. 13, 22 (2013). · DOI
  108. Azimi, S. et al. Allelic polymorphism shapes community function in evolving Pseudomonas aeruginosa populations. ISME J. 14, 1929–1942 (2020). · DOI · Paper page
  109. Allegrucci, M. & Sauer, K. Formation of Streptococcus pneumoniae non-phase-variable colony variants is due to increased mutation frequency present under biofilm growth conditions. J. Bacteriol. 190, 6330–6339 (2008). · DOI · Paper page
  110. Boles, B. R., Thoendel, M. & Singh, P. K. Self-generated diversity produces “insurance effects” in biofilm communities. Proc. Natl. Acad. Sci. USA 101, 16630–16635 (2004). · DOI · Paper page
  111. Ryder, V. J., Chopra, I. & O’Neill, A. J. Increased mutability of Staphylococci in biofilms as a consequence of oxidative stress. PLoS One 7, e47695 (2012). · DOI
  112. Shewaramani, S. et al. Anaerobically grown Escherichia coli has an enhanced mutation rate and distinct mutational spectra. PLoS Genet. 13, e1006570 (2017). · DOI
  113. Maharjan, R. P. & Ferenci, T. A shifting mutational landscape in 6 nutritional states: Stress-induced mutagenesis as a series of distinct stress input-mutation output relationships. PLoS Biol. 15, e2001477 (2017). · DOI
  114. Ahmed, M. N. et al. The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance. NPJ biofilms microbiomes 6, 28 (2020). · DOI · Paper page
  115. Boles, B. R. & Singh, P. K. Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc. Natl. Acad. Sci. USA 105, 12503–12508 (2008). · DOI · Paper page
  116. Santos-Lopez, A. et al. Evolved resistance to a novel cationic peptide antibiotic requires high mutation supply. Evol. Med. Public Health 10, 266–276 (2022). · DOI
  117. Penesyan, A., Nagy, S. S., Kjelleberg, S., Gillings, M. R. & Paulsen, I. T. Rapid microevolution of biofilm cells in response to antibiotics. NPJ biofilms microbiomes 5, 34 (2019). · DOI · Paper page
  118. Van Acker, H., Van Dijck, P. & Coenye, T. Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends Microbiol. 22, 326–333 (2014). · DOI · Paper page
  119. Hibbing, M. E., Fuqua, C., Parsek, M. R. & Peterson, S. B. Bacterial competition: surviving and thriving in the microbial jungle. Nat. Rev. Microbiol. 8, 15–25 (2010). · DOI · Paper page
  120. Trampari, E. et al. Cefotaxime exposure selects mutations within the CA-domain of envZ which promote antibiotic resistance but repress biofilm formation in Salmonella. Microbiol. Spectr. 10, e0214521 (2022). · DOI
  121. Wong, A. & Kassen, R. Parallel evolution and local differentiation in quinolone resistance in Pseudomonas aeruginosa. Microbiol. (Read., Engl.) 157, 937–944 (2011). · DOI
  122. Eklof, J. et al. Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease. Clin. Microbiol. Infect. 28, 990–995 (2022). · DOI
  123. Kolpen, M. et al. Bacterial biofilms predominate in both acute and chronic human lung infections. Thorax 77, 1015–1022 (2022). · DOI · Paper page
  124. Laborda, P., Martinez, J. L. & Hernando-Amado, S. Evolution of Habitat-Dependent Antibiotic Resistance in Pseudomonas aeruginosa. Microbiol. Spectrum 10, e0024722 (2022). · DOI
  125. Stewart, P. S. et al. Search for a Shared Genetic or Biochemical Basis for Biofilm Tolerance to Antibiotics across Bacterial Species. Antimicrob. Agents Chemother. 66, e0002122 (2022). · DOI
  126. Schroeder, J. W., Yeesin, P., Simmons, L. A. & Wang, J. D. Sources of spontaneous mutagenesis in bacteria. Crit. Rev. Biochem. Mol. Biol. 53, 29–48 (2018). · DOI · Paper page
  127. Oliver, A., Canton, R., Campo, P., Baquero, F. & Blazquez, J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251–1254 (2000). · DOI · Paper page
  128. Mena, A. et al. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J. Bacteriol. 190, 7910–7917 (2008). · DOI · Paper page
  129. Oliver, A. & Mena, A. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Clin. Microbiol. Infect. 16, 798–808 (2010). · DOI · Paper page
  130. Driffield, K., Miller, K., Bostock, J. M., O’Neill, A. J. & Chopra, I. Increased mutability of Pseudomonas aeruginosa in biofilms. J. Antimicrobial Chemother. 61, 1053–1056 (2008). · DOI · Paper page
  131. Perez-Osorio, A. C., Williamson, K. S. & Franklin, M. J. Heterogeneous rpoS and rhlR mRNA levels and 16S rRNA/rDNA (rRNA gene) ratios within Pseudomonas aeruginosa biofilms, sampled by laser capture microdissection. J. Bacteriol. 192, 2991–3000 (2010). · DOI
  132. Brown, M. R., Allison, D. G. & Gilbert, P. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J. Antimicrobial Chemother. 22, 777–780 (1988). · DOI · Paper page
  133. Molin, S. & Tolker-Nielsen, T. Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr. Opin. Biotechnol. 14, 255–261 (2003). · DOI · Paper page
  134. Madsen, J. S., Burmolle, M., Hansen, L. H. & Sorensen, S. J. The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol. Med. Microbiol. 65, 183–195 (2012). · DOI · Paper page
  135. Krol, J. E. et al. Increased transfer of a multidrug resistance plasmid in Escherichia coli biofilms at the air-liquid interface. Appl. Environ. Microbiol. 77, 5079–5088 (2011). · DOI
  136. Krol, J. E. et al. Invasion of E. coli biofilms by antibiotic resistance. Plasmids. Plasmid 70, 110–119 (2013). · DOI
  137. Bender, N., Hennes, M. & Maier, B. Mobility of extracellular DNA within gonococcal colonies. Biofilm 4, 100078 (2022). · DOI
  138. Merod, R. T. & Wuertz, S. Extracellular polymeric substance architecture influences natural genetic transformation of Acinetobacter baylyi in biofilms. Appl. Environ. Microbiol. 80, 7752–7757 (2014). · DOI

Cited by

See all 62

Metadata

Authors
Coenye, T., Bové, M., & Bjarnsholt, T.
Venue
npj Biofilms and Microbiomes
Published
2022-10-18
Volume
8
Issue
1
ISSN
2055-5008
Cited by
62
References
7
Language
en
Licence
Funders
  • Lundbeckfonden (R364-2021-1474)
  • Fonds Wetenschappelijk Onderzoek (V401322N)
  • Bijzonder Onderzoeksfonds (BOF.DOC.2018.0023.01)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biofilm antimicrobial susceptibility through an experimental evolutionary lens. https://app.cochat.ai/papers/10.1038/s41522-022-00346-4
The paper
Coenye, T., Bové, M., & Bjarnsholt, T. (2022). Biofilm antimicrobial susceptibility through an experimental evolutionary lens. npj Biofilms and Microbiomes. https://doi.org/10.1038/s41522-022-00346-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.